By Rob Wright and Dan Schell
In May 2021, Industry Standard Research (ISR) conducted a web-based quantitative survey of 154 pharmaceutical/biotech industry participants. The goals of the study included:
- understanding the barriers to restarting business travel
- assessing comfort level with traveling for business in the wake of the pandemic
- predicting when return to in-person events will occur.